[MO27] Mini-Oral Session 27　Head and Neck Cancer 2（Clinical Practice）
【E】

[MO27-3] The mGPS is a potential predictor for early recurrences in patients with HNSCC who underwent chemoradiotherapy

^○Shohei Udagawa¹, Naoki Fukuda¹, Yasuyoshi Sato¹, Yu Fujiwara^1,2, Xiaofei Wang¹, Naomi Hayashi¹, Kenji Nakano¹, Ryosuke Ohki¹, Tetsuya Urasaki¹, Hirotaka Suto¹, Akihiro Ohmoto¹, Makiko Ono¹, Junichi Tomomatsu¹, Takashi Toshiyasu³, Hiroki Mitani⁴, Shunji Takahashi¹ (1.Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, 2.Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, USA., 3.Department of Radiation Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, 4.Department of Head and Neck Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan)